Wendy's rejects takeover proposal from Nelson Peltz’s Trian
Wendy's has rejected a $1.4 billion takeover proposal from Trian Fund Management, led by activist investor Nelson Peltz. The company believes the $7.35-per-share cash offer 'substantially undervalues' the company and does not reflect potential gains from its turnaround strategy. Wendy's has also adopted a shareholder rights plan, or 'poison pill,' to protect itself from a hostile takeover.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ Wendy's rejected a $1.4 billion takeover proposal from Trian Fund Management.
- ✓ The takeover proposal was led by activist investor Nelson Peltz.
- ✓ Wendy's believes the $7.35-per-share cash offer 'substantially undervalues' the company.
- ✓ Wendy's adopted a shareholder rights plan, or 'poison pill,' to protect itself from a hostile takeover.
What changed
Wendy's officially rejected the takeover proposal and adopted a poison pill defense, escalating its resistance to the $1.4 billion bid.
Live updates
-
Wendy's rejects $1.4 billion takeover proposal from Nelson Peltz's Trian
Wendy's has rejected a $1.4 billion takeover proposal from Trian Fund Management, led by activist investor Nelson Peltz. The company believes the $7.35-per-share cash offer 'substantially undervalues' the company and does not reflect potential gains from its turnaround strategy. Wendy's has also adopted a shareholder rights plan, or 'poison pill,' to protect itself from a hostile takeover.
Why it matters
The rejection of the takeover proposal is significant as it indicates Wendy's confidence in its current strategy and growth prospects. Nelson Peltz's Trian Fund Management is known for its activist investing approach, often pushing for changes in companies to increase shareholder value. The adoption of a poison pill defense suggests Wendy's is prepared to defend its independence.
What is confirmed
- Wendy's rejected a $1.4 billion takeover proposal from Trian Fund Management.
- The takeover proposal was led by activist investor Nelson Peltz.
- Wendy's believes the $7.35-per-share cash offer 'substantially undervalues' the company.
- Wendy's adopted a shareholder rights plan, or 'poison pill,' to protect itself from a hostile takeover.
What to watch next
- Wendy's quarterly earnings report to assess progress of its turnaround strategy
- Potential response from Trian Fund Management to Wendy's rejection
- Any developments in Wendy's stock price or shareholder reaction
confidence 100%Sources used for this update (16)
- finance.yahoo.com — Yahoo Finance - Stock Market Live, Quotes, Business & Finance News
- www.cnbc.com — Deals and IPOs - CNBC
- www.cnbc.com — Earnings Announcements - CNBC
- www.cnbc.com — Oil today: Iran, US, crude, wti, brent, trump
- cashwalklabs.io — GM will switch to Nasdaq from the NYSE on Nov. 17
- CNBC — Wendy's rejects takeover proposal from Nelson Peltz’s Trian
- Bloomberg.com — Wendy’s Rejects Takeover Bid From Trian to Take It Private
- WSJ — Wendy’s Rejects $1.4 Billion Buyout Offer from Nelson Peltz’s Trian
- GuruFocus — Nelson Peltz Adds to The Wendy's Co (WEN) -- Shares Look 55% Undervalued on GF Value
- Barron's — Wendy’s Rejects Peltz Takeover Bid. It Has a Plan to Revive Sales.
- www.cbsnews.com — Wendy's rejects $1.4 billion hostile takeover bid - CBS News
- finance.yahoo.com — Wendy's Rejected Nelson Peltz Takeover Offer. What That Means ...
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community